PALO ALTO, CA / ACCESSWIRE / June 26, 2024 / Bioz, Inc., a pioneer in AI-driven research solutions, is delighted to combine efforts with AMSBIO, a global life sciences supplier focused on providing ...

AMSBIO announces the launch of two new microplate-based metabolism stress kits enabling characterization of the main parameters of mitochondrial function in live cells and evaluation of the glycolytic ...

Life science specialists, AMSBIO, have made a new strategic investment to enhance the level of support to its sizeable and growing base of customers across the European Union. On December 30th, 2021, ...

AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion, and proliferation. This expertise in cell culture and the ECM ...

AMSBIO has implemented a program of investment to support the students at Penn State Lehigh Valley, part of Pennsylvania State University, in their transformative Course-based Undergraduate Research ...

AMSBIO announces a new range of different isolation products for scalable and reproducible purification of extracellular vesicles (EV). For researchers looking for a method that recovers the highest ...

AMSBIO announces its sponsorship of the 'Discovering Organoids: Establishment, Culture & Manipulation’ hands-on training course* due to be hosted at Homerton College, University of Cambridge, UK, on ...

AMSBIO (Oxford, UK) offers a comprehensive range of pre-made lentiviral particles for delivering target genes into most types of dividing and non-dividing mammalian cells in vitro and in vivo.

AMSBIO has signed an agreement with Genea Biocells (San Diego, USA) to become global distribution partner to the academic community for its groundbreaking skeletal muscle differentiation product range ...

An Oxfordshire-headquartered life science research supplier has been sold to private equity-backed Europa Biosite. Bristol-based Shaw & Co has provided corporate finance advice to the shareholders of ...